Unmasking Thyroid Cancer: The Power of PET/CT Imaging
Uncover how PET/CT enhances thyroid cancer diagnosis. Explore its insights into tumours, staging, and personalised oncology.
Uncover how PET/CT enhances thyroid cancer diagnosis. Explore its insights into tumours, staging, and personalised oncology.
Lutetium-177 DOTA-EB-FAPi revolutionises oncology by enhancing precision targeting of fibroblast activation protein, improving tumour uptake, and expanding therapeutic applications.
Tumour grading assesses cellular abnormality, predicting cancer growth rate, treatment needs, and informing patient prognosis effectively.
Iodine-131 Sodium Iodide plays a pivotal role in diagnosing and treating thyroid diseases, including carcinomas, through targeted radiotherapy and imaging.
Proton radiation therapy revolutionises cancer treatment by precisely targeting tumours while sparing healthy tissues.
Radioactive cancer therapies utilise targeted radiation to damage tumour DNA, halting their growth and preventing further spread.
What are radiopharmaceuticals? They are radioactive drugs used for diagnosing and treating various medical conditions.
Astatine-211 Sodium Astatide, evolving thyroid treatment, enters trials, promising enhanced precision and safety over traditional Iodine-131 NaI therapy.
Technetium-99m sodium pertechnetate is pivotal for brain, thyroid, cardiac imaging, and cancer detection in nuclear medicine.
Iodine-131 sodium iodide, a radioactive isotope, is used in diagnosing and treating thyroid disorders and specific cancer therapies.
Iodine-123 Sodium Iodide capsules aid in diagnosing thyroid disorders, providing vital insights into thyroid function and structure.
Differentiated thyroid cancer is a common endocrine tumor with increasing incidence and excellent prognosis.
Topics on MRI, ablation, lacrimal scintigraphy and enchondroma.